A review of telbivudine for the management of chronic hepatitis B virus infection

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.10, 2008-10, pp. : 1351-1361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telbivudine for Chronic Hepatitis B. A Review

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 4, 2008-10 ,pp. : 245-248

Bentham Science Publishers

Access to resources Recommend Favorite

Telbivudine: A Review of its Use in Compensated Chronic Hepatitis B

By McKeage Kate Keam Susan J.

Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. : 1857-1883

Adis International

Access to resources Recommend Favorite

Telbivudine myopathy in a patient with chronic hepatitis B

By Wang Min

International Journal of Clinical Pharmacy, Vol. 34, Iss. 3, 2012-06 ,pp. : 422-425

Springer Publishing Company

Access to resources Recommend Favorite

Telbivudine for chronic hepatitis B: the GLOBE trial

By Yuen Man-Fung Lai Ching-Lung

Future Virology, Vol. 3, Iss. 4, 2008-07 ,pp. : 317-323

Future Medicine

Access to resources Recommend Favorite

Clevudine for the treatment of chronic hepatitis B virus infection

By Hui Chee-Kin Lau George KK

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. : 1277-1284

Informa Healthcare

Access to resources Recommend Favorite